AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0155
0.00 (0.00%)
Apr 18, 2024, 12:00 PM EDT - Market open

AXIM Biotechnologies Statistics

Total Valuation

AXIM has a market cap or net worth of $3.68 million. The enterprise value is $9.47 million.

Market Cap 3.68M
Enterprise Value 9.47M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

AXIM has 237.65 million shares outstanding. The number of shares has increased by 178.37% in one year.

Shares Outstanding 237.65M
Shares Change (YoY) +178.37%
Shares Change (QoQ) +111.48%
Owned by Insiders (%) 33.26%
Owned by Institutions (%) n/a
Float 174.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 106.87
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 274.83
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.01

Current Ratio 0.01
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -13.71

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -178.48%
Return on Capital (ROIC) n/a
Revenue Per Employee $5,745
Profits Per Employee -$1.20M
Employee Count 6
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

In the past 12 months, AXIM has paid $1.07 million in taxes.

Income Tax 1.07M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -53.03% in the last 52 weeks. The beta is 1.40, so AXIM's price volatility has been higher than the market average.

Beta (1Y) 1.40
52-Week Price Change -53.03%
50-Day Moving Average 0.01
200-Day Moving Average 0.02
Relative Strength Index (RSI) 57.01
Average Volume (30 Days) 466,203

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, AXIM had revenue of $34,468 and -$7.22 million in losses. Loss per share was -$0.03.

Revenue 34,468
Gross Profit -392,637
Operating Income -3.14M
Pretax Income -7.06M
Net Income -7.22M
EBITDA -2.71M
EBIT -3.14M
Loss Per Share -$0.03
Full Income Statement

Balance Sheet

The company has $23,220 in cash and $5.81 million in debt, giving a net cash position of -$5.79 million or -$0.02 per share.

Cash & Cash Equivalents 23,220
Total Debt 5.81M
Net Cash -5.79M
Net Cash Per Share -$0.02
Equity / Book Value -5.96M
Book Value Per Share -0.03
Working Capital -4.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.37 million and capital expenditures $8,710, giving a free cash flow of -$1.36 million.

Operating Cash Flow -1.37M
Capital Expenditures 8,710
Free Cash Flow -1.36M
FCF Per Share -$0.00
Full Cash Flow Statement

Margins

Gross margin is -1,139.13%, with operating and profit margins of -9,107.76% and -20,939.79%.

Gross Margin -1,139.13%
Operating Margin -9,107.76%
Pretax Margin -20,472.62%
Profit Margin -20,939.79%
EBITDA Margin -7,868.62%
EBIT Margin -9,107.76%
FCF Margin -3,936.55%

Dividends & Yields

AXIM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -178.37%
Shareholder Yield -178.37%
Earnings Yield -195.94%
FCF Yield -36.84%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AXIM has an Altman Z-Score of -27.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -27.93
Piotroski F-Score 3